Impact of ketone bodies on age-related inflammation and healthspan extension
酮体对年龄相关炎症和延长健康寿命的影响
基本信息
- 批准号:10116685
- 负责人:
- 金额:$ 24.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-01-01 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAcuteAcute Lung InjuryAdipose tissueAdultAgeAgingAnti-Inflammatory AgentsAntiinflammatory EffectAtherosclerosisBacterial InfectionsCASP1 geneCaloric RestrictionCell physiologyCellsChronicChronic DiseaseCoenzyme ADataDevelopmentDiseaseEducational process of instructingElderlyEnzymesEstersFacultyFatty AcidsFatty acid glycerol estersFibrosisGeneticGenus HippocampusGlucoseGlucose tolerance testGoalsGrantHealthHepaticHost DefenseHumanImmuneImmune TargetingImmune responseImmune systemImpaired cognitionImpairmentIn VitroIndividualInfectionInfiltrationInflammagingInflammasomeInflammationInflammatoryInflammatory ResponseInterleukin-1 betaInterleukin-18InterventionKetone BodiesKetonesKetosisLabelLeadershipLeukocytosisLinkLongevityLungLung infectionsLyaseMeasuresMediatingMetabolicMetabolic DiseasesMetabolismMethodsModelingMusMyelogenousNutritionalOutcomeParabiosisPathologyPathway interactionsPopulationPositioning AttributeProcessProductionRegulationRisk FactorsRoleScientistSignal TransductionSourceStaphylococcus aureusStarvationSterilityTestingTissue ModelTissuesTrainingVirus DiseasesVisceralWritingage relatedagedantimicrobialautocrinebasebeta-Hydroxybutyratebone losscareercell agecytokinecytotoxicityexperienceexperimental studyfeedingfunctional declineglycemic controlhealthspanimprovedin vitro Assayin vivoinsulin toleranceketogenic dietketogenticlung injurymacrophagemetabolic ratemimeticsmouse modelneutrophilnew therapeutic targetnovelnovel therapeuticspreferencepreventprogramsprotective effectprotein complexresponseresponsible research conductsenescencetargeted treatmenttenure tracktranscriptome sequencinguptake
项目摘要
Project Summary
Aging is characterized by systemic chronic low-grade inflammation. The basic mechanisms leading to this
inflammation are unknown, making it impossible to develop targeted therapies to prevent chronic disease in
the elderly. While the precise source of this increased inflammation is not known, a primary candidate is the
NLRP3 inflammasome. Activation of inflammasomes is a highly regulated process that requires two signals
leading to activation of caspase-1 and secretion of the proinflammatory cytokines IL-1β and IL-18 from innate
immune cells. Aberrant activation of the NLRP3 inflammasome contributes to chronic inflammation as old mice
with genetic deletion of NLRP3 are protected from age-related diseases that limit healthspan, including
cognitive decline, metabolic disease, bone loss, and immune senescence. Lifespan-extending interventions
such as calorie restriction reduce NLRP3 activation and are characterized by a metabolic adaptation that leads
to increased production of the ketone body β-hydroxybutyrate (BHB). Importantly, BHB is sufficient to inhibit
NLRP3 activation in innate immune cells from aged mice and humans. The overall hypothesis of this proposal
is that the negative regulatory effects of BHB upon NLRP3 activation can alleviate dysregulated inflammation
during aging. This hypothesis will be tested in two aims: (1) Determine the protective role of ketones in
dysregulated inflammatory responses against infection (1a) or chronic sterile inflammation in visceral adipose
tissue (1b); and (2) Define cellular metabolic changes during aging that regulate innate immune inflammation.
Acute inflammatory responses will be evaluated in lung infections or lung injury models. Sterile inflammation
will be evaluated in visceral adipose tissue by leukocytosis, pro-inflammatory immune profiles, and ensuing
metabolic health will be tested by glucose and insulin tolerance tests. The ketogenic pathway is being targeted
by conditional deletion of ketogenic enzyme in innate immune cell subsets including neutrophils and
macropages. The proposal also seeks additional scientific training for the candidate in experimental methods,
including in vitro assays, CyTOF, and RNAseq analysis. This proposal also incorporates training in
professional development including responsible conduct of research, teaching experience, grant writing, and
leadership opportunities. Completion of these objectives will make the candidate ideally suited for obtaining a
tenure-track faculty position and becoming an independent scientist. These studies will highlight BHB as a
regulatory metabolite that coordinates metabolism with the immune system to dampen inflammation. The long-
term goal of this application is to prepare the candidate for transition to an independent scientific career
studying innate immune origins and regulation of inflammation during aging, ultimately identifying novel
therapeutic targets to decrease age-related inflammation and extend healthspan.
项目摘要
衰老的特征是全身性慢性炎症。导致此的基本机制
炎症是未知的,使得无法开发针对性疗法以预防慢性病
较早的。虽然尚不清楚这种增加感染的确切来源,但主要候选人是
NLRP3炎症体。激活炎症是一个高度调节的过程,需要两个信号
导致caspase-1的激活和促炎细胞因子IL-1β和IL-18的分泌
免疫细胞。 NLRP3炎性体的异常激活会导致慢性炎症,因为老鼠
NLRP3的遗传缺失受到保护,免受与年龄相关的疾病,这些疾病限制了健康状况
认知能力下降,代谢疾病,骨质流失和免疫感应。延长寿命的干预措施
例如卡路里限制减少NLRP3激活,并以代谢适应为特征
重要的是,BHB足以抑制
来自老年小鼠和人类的先天免疫小球中的NLRP3激活。该提议的总体假设
是,BHB对NLRP3激活的负调节作用会减轻注射失调
在衰老期间。该假设将以两个目的进行检验:(1)确定酮在
内脏脂肪中针对感染(1a)或慢性无菌感染的炎症反应失调
组织(1b); (2)在调节先天免疫炎症的衰老过程中定义细胞代谢变化。
将在肺部感染或肺损伤模型中评估急性炎症反应。无菌炎症
将通过白细胞增多,促炎性免疫特征在内脏脂肪组织中评估,并确保
代谢健康将通过葡萄糖和胰岛素耐受性测试测试。生酮途径是针对的
通过有条件地删除了先天性免疫小球子集中的生酮酶,包括中性粒细胞和
宏观。该提案还寻求针对实验方法的候选人的其他科学培训,
包括体外测定,Cytof和RNASEQ分析。该建议还包括
专业发展,包括负责任的研究,教学经验,赠款写作和
领导机会。这些目标的完成将使候选人非常适合获得
终身教师职位并成为独立科学家。这些研究将重点介绍BHB作为
调节代谢物,可与免疫系统互动以抑制炎症。长期
该应用程序的任期目标是为候选人做好过渡到独立科学职业的准备
研究先天免疫的起源和衰老期间炎症的调节,最终确定了新型
治疗靶标可减少与年龄相关的感染并扩展健康范围。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Emily Lauren Goldberg其他文献
Emily Lauren Goldberg的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Emily Lauren Goldberg', 18)}}的其他基金
Discovering mechanisms of tissue-resident immune aging
发现组织驻留免疫衰老的机制
- 批准号:
10472369 - 财政年份:2022
- 资助金额:
$ 24.9万 - 项目类别:
Impact of ketone bodies on age-related inflammation and healthspan extension
酮体对年龄相关炎症和延长健康寿命的影响
- 批准号:
10263283 - 财政年份:2019
- 资助金额:
$ 24.9万 - 项目类别:
Impact of ketone bodies on age-related inflammation and healthspan extension
酮体对年龄相关炎症和延长健康寿命的影响
- 批准号:
10447734 - 财政年份:2019
- 资助金额:
$ 24.9万 - 项目类别:
相似国自然基金
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
- 批准号:82370084
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
CDK4/6抑制下调衰老中性粒细胞促炎效应改善急性肺损伤的机制和干预研究
- 批准号:82302445
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于肺间充质干细胞源外泌体lncRNA表达谱差异探讨益气活血解毒法改善脓毒症急性肺损伤的机制
- 批准号:82374400
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
基于巨噬细胞炎性小体活化探究木犀草素治疗急性肺损伤的新机制
- 批准号:82374186
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
DUSP2介导自噬调控气管上皮细胞炎症在急性肺损伤中的机制研究
- 批准号:82360379
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Resident Memory T cells in Chronic Kidney Disease
慢性肾脏病中的常驻记忆 T 细胞
- 批准号:
10676628 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Minimally Invasive High Intensity Therapeutic Ultrasound for the Treatment of Obstructive Hypertrophic Cardiomyopathy
微创高强度超声治疗梗阻性肥厚型心肌病
- 批准号:
10603460 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Spatiotemporal regulation of polyploidy in zebrafish cardiac tissue regeneration
斑马鱼心脏组织再生中多倍体的时空调控
- 批准号:
10736051 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Impact of gut bacterial metabolites on lung function and disease
肠道细菌代谢对肺功能和疾病的影响
- 批准号:
10663755 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Interleukin-27 in host response to Legionella infection
Interleukin-27 在宿主对军团菌感染的反应中
- 批准号:
10745091 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别: